Detalhe da pesquisa
1.
Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy.
J Viral Hepat
; 21(7): 475-9, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24750394
2.
Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance.
J Viral Hepat
; 18(1): 11-6, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20088890
3.
Treatment of chronic hepatitis C in HIV-infected patients with compensated liver cirrhosis.
J Viral Hepat
; 18(8): 542-8, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20819149
4.
Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients.
J Viral Hepat
; 18(5): 325-30, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20456635
5.
Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes.
J Viral Hepat
; 17(12): 866-71, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20088891
6.
Predictors of severe hepatic steatosis using abdominal ultrasound in HIV-infected patients.
HIV Med
; 10(1): 53-9, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19018879
7.
Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations.
J Viral Hepat
; 16(12): 895-6, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19413691
8.
Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection.
Virology
; 450-451: 336-49, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24503097